HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Chemicals Agency Leverages 2010 Lessons To Ready Firms For REACH 2013

This article was originally published in The Rose Sheet

Executive Summary

With the passing of the first registration deadline under Europe’s REACH program and the evaluation of registered dossiers underway, the European Chemicals Agency is working to motivate and support companies subject to the next deadline.

You may also be interested in...



REACH Compliance Suffers From Poor Supply-Chain Communication – ECHA

"Only representatives" registering chemicals under REACH on behalf of downstream users that import the substances from non-EU-based manufacturers are "more at risk of non-compliance," the European Chemicals Agency says, calling for improved communication in chemical supply chains. ECHA's Enforcement Forum found a third of only representatives to be in breach of the EU's REACH law.

EC Looks To Reduce REACH Burden For Smaller Firms

REACH is already making an impact on chemicals safety in Europe, according to a report from the European Commission. However, improvements can be made, including fee reductions for small and middle-sized enterprises, the EC says.

ECHA Pursues Fees From Misclassified REACH Registrants

Registrants who have misclassified their entity size in order to pay smaller registration fees under Europe’s REACH chemicals program are being asked to submit new registrations or appeal to the agency’s Board of Appeal within three months, according to a Nov. 16 release from the agency.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel